Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032

icon1
USD 30.39 BN
MARKET SIZE, 2032
icon2
CAGR 6.2%
(2026-2032)
icon3
265
REPORT PAGES
icon4
210
MARKET TABLES

OVERVIEW

pharmaceutical-manufacturing-equipment-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global pharmaceutical manufacturing equipment market is likely to be valued at USD 21.24 billion in 2026 and USD 30.39 billion by 2032, registering a CAGR of 6.2% during the forecast period. Demand for pharmaceutical manufacturing equipment is driven by the rising production of generic and biologic drugs, increasing investments in pharmaceutical R&D, and the expansion of manufacturing facilities worldwide. Growing emphasis on regulatory compliance, quality assurance, and process automation further support market growth. Additionally, the adoption of advanced technologies, such as continuous manufacturing and single-use systems, enhances operational efficiency and accelerates equipment upgrades across pharmaceutical production sites.

KEY TAKEAWAYS

  • By Region
    By region, Asia Pacific is expected to dominate the pharmaceutical manufacturing equipment market, growing at a CAGR of 6.9% during the forecast period.
  • By Equipment Type
    By equipment type, the packaging machines segment is expected to hold a 52.4% share of the market in 2026.
  • By End-Product Type
    By end-product type, liquid segment is expected to grow at the highest CAGR during the forecast period.
  • By Technology
    By technology, the automatic segment is expected to record a CAGR of 6.6% from 2026 to 2032.
  • Competitive Landscape - Key Players
    GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), and Syntegon Technology GmbH (Germany) were identified as some of the star players in the global pharmaceutical manufacturing equipment market, given their strong market share and product footprint.
  • Competitive Landscape - Startups/SMEs
    MG2 s.r.l (Italy), Fette Compacting (Germany), and CVC Technologies (US), among others, have established themselves as specialized pharmaceutical manufacturing equipment providers by building strong capabilities in capsule filling, tablet compression, and packaging solutions. These companies are strengthening their market presence by offering application-specific equipment designed to enhance precision, efficiency, and regulatory compliance across solid dosage and packaging lines. Through continuous technological upgrades, automation integration, and strategic global expansion initiatives, they are scaling their commercial footprint in the global pharmaceutical manufacturing equipment market.

Major pharmaceutical and life sciences companies are integrating advanced manufacturing equipment across formulation, filling, packaging, and inspection processes to enhance production efficiency and product quality. Several equipment manufacturers are expanding their portfolios with automated, continuous manufacturing systems, single-use technologies, and integrated digital solutions to support high-volume and complex drug production, including biologics and sterile injectables. These developments accelerate the modernization of pharmaceutical facilities and strengthen the role of advanced manufacturing equipment in ensuring regulatory compliance, scalability, and cost-effective operations across global pharmaceutical manufacturing sites.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The pharmaceutical manufacturing equipment market is shifting from conventional tablet and liquid processing systems to advanced solutions, such as biologics processing, AI-based inspection, and cell and gene therapy equipment. Demand from pharmaceutical companies, CDMOs, and vaccine manufacturers is creating new growth opportunities for equipment providers. Companies focus on automation, digital integration, and compliance-driven systems to improve production efficiency and reduce costs. These trends are supporting faster drug development and more scalable manufacturing operations.

pharmaceutical-manufacturing-equipment-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing commercialization of biologics and complex formulations
  • Growing preference for personalized medicines and targeted therapies
RESTRAINTS
Impact
Level
  • High capital expenditure requirements
  • Issues related to integration with existing systems
OPPORTUNITIES
Impact
Level
  • Expansion of contract development and manufacturing organizations
  • Mounting demand for sterile and aseptic injectable drugs
CHALLENGES
Impact
Level
  • Requirement for frequent technological upgrades
  • Complex validation and revalidation cycles

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing commercialization of biologics and complex formulations

The increasing development and commercialization of biologics, biosimilars, vaccines, monoclonal antibodies, and advanced drug delivery systems are significantly influencing the demand for pharmaceutical manufacturing equipment. Unlike conventional small-molecule drugs, biologics require highly controlled production environments, sterile processing systems, and precision-based filling technologies. This drives investments in advanced filling machines, sterilization equipment, spray drying systems, and high-performance mixing and blending machines.

Restraint: High capital expenditure requirements

High capital expenditure remains a primary restraint in the pharmaceutical manufacturing equipment market. Equipment such as tablet compression presses, high-speed filling machines, sterilization systems, and automated inspection units requires substantial upfront investment. The total cost extends beyond the purchase price and includes installation, facility modification, cleanroom integration, validation, automation software, and operator training.

Opportunity: Expansion of contract development and manufacturing organizations

The expansion of Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) represents a significant opportunity for the pharmaceutical manufacturing equipment market. Pharmaceutical companies are increasingly outsourcing production activities to reduce capital expenditure, accelerate time to market, and focus on core competencies, such as research and commercialization.

Challenge: Requirement for frequent technological upgrades

Rapid technological advancements are creating continuous upgrade pressure in the pharmaceutical manufacturing equipment market. Equipment suppliers are increasingly integrating automation, robotics, artificial intelligence-based inspection systems, real-time monitoring sensors, and data analytics platforms into packaging machines, filling systems, granulation units, and inspection equipment.

PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Supplies end-to-end process equipment for pharmaceutical production including mixing, granulation, drying, tablet coating, sterile/aseptic processing, lyophilizers and single-use process skids for both batch and continuous manufacturing Enables scalable, validated production with improved yield and reproducibility | Reduces contamination risk through closed/aseptic designs | Supports regulatory compliance and accelerates time-to-market
Provides automated processing and primary/secondary packaging lines: tablet handling, capsule filling, blistering, cartoning, serialization, labeling and integrated end-of-line systems for oral solids and parenterals Delivers high throughput and packaging accuracy | Lowers manual intervention and labor cost | Simplifies serialization and traceability | Improves product protection and shelf presentation
Offers aseptic and non-aseptic filling systems, sterilization and inspection equipment, blister and bottle lines, track-and-trace solutions, and process automation for sterile drug manufacture Raises product quality and batch consistency through validated aseptic technology | Strengthens GMP compliance with integrated inspection and serialization | Reduces total cost of ownership via reliable automation
Supplies capsule manufacturing and filling systems, tablet compression tooling, coating machines, blister packaging and visual inspection systems tailored for small to large scale pharmaceutical producers Provides cost-effective, energy-efficient equipment suited to emerging and established markets | Enables modular scaling of capacity | Improves production uptime | Helps meet regulatory packaging standards
Delivers analytical and manufacturing support equipment including bioprocess single-use systems, environmental and process monitoring, sterilizers, analytical instruments and fill-finish support for biologics and small molecules Strengthens quality control and process characterization | Supports scale-up from R&D to commercial production | Offers validated systems and service support that reduce technical risk and speed regulatory submissions

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The pharmaceutical manufacturing equipment ecosystem comprises raw material & component suppliers, core equipment manufacturers, system integrators that collectively support end-to-end pharmaceutical production, and end users. Component suppliers provide automation, fluid control, and process technologies that are integrated into primary manufacturing and packaging equipment by OEMs. System integrators enable seamless installation, validation, and digital connectivity across production lines. End users, including pharmaceutical and biopharmaceutical manufacturers, drive the demand through requirements for compliance, scalability, and high-efficiency manufacturing, supporting continuous innovation and technology upgrades across the ecosystem.

pharmaceutical-manufacturing-equipment-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

pharmaceutical-manufacturing-equipment-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Pharmaceutical Manufacturing Equipment Market, By Equipment Type

The packaging machines segment is expected to dominate the market during the forecast period due to increasing demand for high-speed, compliant, and automated packaging solutions. Growing pharmaceutical production and stringent labeling and serialization requirements are also supporting segment growth.

Pharmaceutical Manufacturing Equipment Market, By End-Product Type

The liquid segment is projected to grow at the fastest rate during the forecast period driven by the mounting demand for injectables, biologics, and sterile formulations. Expansion of vaccine and parenteral drug manufacturing is further accelerating equipment demand in this segment.

Pharmaceutical Manufacturing Equipment Market, By Technology

The automatic segment is anticipated to witness the fastest growth between 2026 and 2032 as manufacturers focus on reducing manual intervention and improving operational efficiency. Increasing adoption of automation and digital control systems is supporting advanced manufacturing practices.

REGION

Asia Pacific to be fastest-growing region across global pharmaceutical manufacturing equipment market during forecast period

Asia Pacific is expected to grow at the fastest CAGR in the pharmaceutical manufacturing equipment market during the forecast period, driven by expanding pharmaceutical production capacities in India, China, and Japan. Increasing investments in generic drug manufacturing, solid dosage equipment, and cost-effective packaging solutions are supporting regional demand. The presence of large integrated equipment providers and emerging local manufacturers is strengthening supply capabilities and enabling broader adoption of advanced manufacturing systems across the region.

pharmaceutical-manufacturing-equipment-market Region

PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX

In the global pharmaceutical manufacturing equipment market matrix, Syntegon Technology GmbH (Germany) and Körber AG (Germany) are positioned as STAR players with strong market presence and broad equipment portfolios across processing, packaging, and inspection solutions. Their integrated capabilities and global service networks support large-scale pharmaceutical and biopharmaceutical manufacturing operations. Thermo Fisher Scientific Inc (US), positioned as an Emerging Leader, is strengthening its presence through advanced bioprocessing technologies, expansion of high-value equipment offerings, and strategic investments aligned with growing demand for biologics and complex drug manufacturing.

pharmaceutical-manufacturing-equipment-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 20.12 Billion
Market Forecast in 2032 (Value) USD 30.39 Billion
Growth Rate CAGR of 6.2% from 2026–2032
Years Considered 2021–2032
Base Year 2025
Forecast Period 2026–2032
Units Considered Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Equipment Type:
    • Packaging Machines
    • Filling Machines
    • Spray Drying Equipment
    • Mixing & Blending Machines
    • Milling Equipment
    • Extrusion Equipment
    • Tablet Compression Presses
    • Inspection Equipment
    • Granulation Equipment
    • and Sterilization Equipment
  • By End-Product Type: Solid and Liquid
  • By Technology: Semi-automatic and Automatic
Regional Scope North America, Europe, Asia Pacific, and RoW

WHAT IS IN IT FOR YOU: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET REPORT CONTENT GUIDE

pharmaceutical-manufacturing-equipment-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Tablet & Capsule Manufacturing Equipment Supplier
  • Comparative benchmarking of high-speed tablet press technologies (rotary vs. single-punch) across throughput, rejection rates, and API compatibility
  • Analysis of encapsulation equipment advancements for controlled-release formulations
  • Cost-structure modeling for equipment qualification and GMP compliance (21 CFR Part 11)
  • Strengthen competitive positioning against European OEMs (Fette, Korsch, IMA)
  • Identify growth opportunities in emerging CDMO and generic drug manufacturing markets
  • Support go-to-market strategy for next-generation continuous manufacturing platforms
Sterile Fill-Finish Equipment Provider
  • Performance analysis of aseptic filling lines for vials, syringes, and cartridges across fill accuracy, particulate control, and line speed
  • Benchmarking of isolator vs. RABS containment technology for biologics
  • Regulatory pathway assessment for Annex 1 (EU GMP) and FDA aseptic processing compliance
  • Accelerate commercialization with validated use cases in biologics, vaccines, and cell & gene therapy
  • Identify high-value partnership opportunities with CDMOs expanding sterile capacity
  • Support capital investment decisions and equipment lifecycle planning with market validation data
Pharmaceutical Mixing & Granulation Equipment Manufacturer
  • Technology benchmarking of wet granulation, dry granulation (roller compaction), and direct compression across API sensitivity, batch size scalability, and regulatory acceptance
  • Process analytical technology (PAT) integration assessment for real-time monitoring
  • Supply chain analysis for critical spare parts and validation documentation requirements
  • Identify strategic entry points in high-growth segments (continuous manufacturing, potent compound handling)
  • Strengthen differentiation against competitors offering integrated line solutions
  • Enable partnership development with pharmaceutical automation and digitalization vendors
Cleanroom & Containment Solutions Provider
  • Application mapping of containment technologies (OEB levels 1–5) across oncology, hormone, and HPAPI manufacturing environments
  • Benchmarking of modular cleanroom systems vs. traditional fixed infrastructure for flexibility and cost-effectiveness
  • Regulatory compliance gap analysis across FDA, EMA, and WHO GMP facility standards
  • Expand addressable market into high-potency and biopharmaceutical manufacturing segments
  • Identify strategic OEM partnerships with equipment suppliers requiring integrated containment solutions
  • Support Series B/C fundraising or M&A positioning with validated market sizing and segmentation data
Pharmaceutical Packaging Equipment Developer
  • Performance benchmarking of primary and secondary packaging lines (blister, bottling, labeling) across speed, serialization compliance, and changeover efficiency
  • Assessment of track-and-trace technology integration for DSCSA and EU FMD regulatory adherence
  • Analysis of sustainable packaging equipment adaptations (recyclable materials, reduced footprint) across major markets
  • Strengthen market positioning against European and Asian packaging OEMs
  • Identify growth opportunities in unit-dose and patient-adherence packaging for specialty pharma
  • Assess technology partnership requirements with serialization software and vision inspection system vendors

RECENT DEVELOPMENTS

  • January 2026 : IMA Industria Macchine Automatiche S.p.A partnered with Sharp Sterile Manufacturing to expand a sterile filling facility in Massachusetts, installing a fully automated isolated filling line for ready-to-use vials with integrated robotics, advanced weight control, and lyophilization technologies.
  • April 2025 : Syntegon Technology GmbH introduced the MLD Advanced filling machine for ready-to-use nested syringes, enabling high-throughput production with integrated in-process control for enhanced quality assurance.
  • June 2025 : Körber AG expanded its manufacturing presence with a new facility in Portugal, strengthening production capacity and supporting long-term investment in innovation and operational capabilities.
  • March 2025 : GEA Group Aktiengesellschaft launched the kytero 10 single-use disk stack centrifuge designed for small-scale biopharmaceutical production and product development applications.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
30
2
EXECUTIVE SUMMARY
 
 
 
 
 
35
3
PREMIUM INSIGHTS
 
 
 
 
 
40
4
MARKET OVERVIEW
Harnessing automation and personalized medicine to drive growth amid regulatory and technological challenges.
 
 
 
 
 
44
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING COMMERCIALIZATION OF BIOLOGICS AND COMPLEX FORMULATIONS
 
 
 
 
 
 
4.2.1.2
GROWING PREFERENCE FOR PERSONALIZED MEDICINES AND TARGETED THERAPIES
 
 
 
 
 
 
4.2.1.3
RAPID ADVANCES IN AUTOMATION, DIGITAL MONITORING, AND INDUSTRY 4.0 TECHNOLOGIES
 
 
 
 
 
 
4.2.1.4
ESCALATING GENERIC DRUG PRODUCTION
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH CAPITAL EXPENDITURE REQUIREMENTS
 
 
 
 
 
 
4.2.2.2
ISSUES RELATED TO INTEGRATION WITH EXISTING SYSTEMS
 
 
 
 
 
 
4.2.2.3
IMPLEMENTATION OF STRINGENT REGULATORY COMPLIANCE STANDARDS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANSION OF CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
 
 
 
 
 
 
4.2.3.2
MOUNTING DEMAND FOR STERILE AND ASEPTIC INJECTABLE DRUGS
 
 
 
 
 
 
4.2.3.3
RISING DEPLOYMENT OF ADVANCED INSPECTION AND SERIALIZATION TECHNOLOGIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
REQUIREMENT FOR FREQUENT TECHNOLOGICAL UPGRADES
 
 
 
 
 
 
4.2.4.2
COMPLEX VALIDATION AND REVALIDATION CYCLES
 
 
 
 
 
 
4.2.4.3
TECHNICAL AND OPERATIONAL CHALLENGES RELATED TO SMALL-BATCH PRODUCTION
 
 
 
 
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Discover how evolving industry dynamics and pricing trends shape pharmaceutical manufacturing strategies.
 
 
 
 
 
57
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.3
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL BIOPHARMACEUTICAL & VACCINE MANUFACTURING INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN GLOBAL GENERIC DRUG & ORAL SOLID DOSAGE MANUFACTURING INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025
 
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022–2025
 
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022–2025
 
 
 
 
 
5.6
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 8479)
 
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 8479)
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
KEY CONFERENCES AND EVENTS, 2026
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
INOXPA STRENGTHENS AVVA PHARMACEUTICALS’ MANUFACTURING CAPABILITIES THROUGH MODULAR PHARMACEUTICAL PROCESSING SYSTEM
 
 
 
 
 
 
5.10.2
GEA GROUP INSTALLS PSD-3 PHARMACEUTICAL SPRAY DRYER AT CHUGAI PHARMACEUTICAL’S FJ3 FACILITY TO PROCESS PHARMACEUTICAL COMPOUNDS
 
 
 
 
 
 
5.10.3
ZAMBON COMPANY AND IMA ACTIVE COLLABORATE ON PROCESS OPTIMIZATION PROJECT TO ENHANCE BATCH CONSISTENCY AND QUALITY
 
 
 
 
 
 
5.10.4
ACG HELPS INDIAN PHARMACEUTICAL COMPANY RETROFIT B MAX MACHINE WITH NITROGEN-ENHANCED PURGING SYSTEM TO IMPROVE STABILITY AND SHELF LIFE
 
 
 
 
 
 
5.10.5
SYNTEGON PROVIDES AIM 5022S PLATFORM TO JIANGSU JINDIKE PHARMACEUTICAL TO ENHANCE INSPECTION EFFICIENCY AND ACCURACY
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON EQUIPMENT TYPES
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, AND INNOVATIONS
AI-driven innovations redefine pharmaceutical manufacturing with smart sensors, automation, and strategic patent insights.
 
 
 
 
 
87
 
6.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
CONTINUOUS MANUFACTURING
 
 
 
 
 
 
6.1.2
DIGITAL TWIN
 
 
 
 
 
 
6.1.3
STERILE AND ASEPTIC PROCESSING
 
 
 
 
 
 
6.1.4
SOLID DOSAGE MANUFACTURING
 
 
 
 
 
 
6.1.5
AUTOMATION AND ROBOTICS
 
 
 
 
 
 
6.1.6
INTERNET OF THINGS (IOT) AND SMART SENSORS
 
 
 
 
 
6.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
COMPUTER-AIDED DESIGN (CAD) AND COMPUTER-AIDED MANUFACTURING (CAM)
 
 
 
 
 
 
6.2.2
ADVANCED CNC MACHINING AND PRECISION MANUFACTURING
 
 
 
 
 
6.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
3D PRINTING
 
 
 
 
 
 
6.3.2
INDUSTRIAL AUTOMATION SYSTEMS
 
 
 
 
 
6.4
TECHNOLOGY ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
6.6
IMPACT OF AI ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.6.2
BEST PRACTICES FOLLOWED BY OEMS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
6.6.3
CASE STUDIES RELATED TO AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT AI-INTEGRATED PHARMACEUTICAL MANUFACTURING EQUIPMENT
 
 
 
 
7
REGULATORY LANDSCAPE
Navigate complex global regulations with a comprehensive guide to regional compliance and industry standards.
 
 
 
 
 
99
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
7.1.3
REGULATIONS
 
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
Discover unmet needs and stakeholder influences shaping buying decisions in pharmaceutical equipment.
 
 
 
 
 
104
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS OF EQUIPMENT TYPES
 
 
 
 
 
9
END USERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT
Discover how diverse end users drive innovation in pharmaceutical manufacturing equipment.
 
 
 
 
 
111
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PHARMACEUTICAL MANUFACTURING COMPANIES
 
 
 
 
 
 
9.3
CONTRACT MANUFACTURING ORGANIZATIONS
 
 
 
 
 
10
MANUFACTURING PROCESSES OF PHARMACEUTICAL EQUIPMENT
Streamline pharmaceutical equipment efficiency with advanced manufacturing and stringent quality control processes.
 
 
 
 
 
113
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
FORMULATION PROCESS
 
 
 
 
 
 
10.3
TABLETING & ENCAPSULATION PROCESS
 
 
 
 
 
 
10.4
ASEPTIC PROCESS
 
 
 
 
 
 
10.5
PACKAGING PROCESS
 
 
 
 
 
 
10.6
QUALITY CONTROL PROCESS
 
 
 
 
 
11
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
Market Size & Growth Rate Forecast Analysis to 2032 in USD Million and Units | 124 Data Tables
 
 
 
 
 
116
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
PACKAGING MACHINES
 
 
 
 
 
 
 
11.2.1
INCREASING PRODUCT AND STOCK KEEPING UNIT PROLIFERATION TO BOOST SEGMENTAL GROWTH
 
 
 
 
 
11.3
FILLING MACHINES
 
 
 
 
 
 
 
11.3.1
RISING STERILE AND ASEPTIC MANUFACTURING TO CONTRIBUTE TO SEGMENTAL GROWTH
 
 
 
 
 
11.4
SPRAY DRYING EQUIPMENT
 
 
 
 
 
 
 
11.4.1
ESCALATING NUMBER OF POORLY SOLUBLE DRUG MOLECULES TO FOSTER SEGMENTAL GROWTH
 
 
 
 
 
11.5
MIXING & BLENDING MACHINES
 
 
 
 
 
 
 
11.5.1
MOUNTING CONSUMPTION OF SOLID ORAL DOSAGE FORMS TO BOLSTER SEGMENTAL GROWTH
 
 
 
 
 
11.6
MILLING EQUIPMENT
 
 
 
 
 
 
 
11.6.1
RISING NEED FOR TIGHT PARTICLE SIZE CONTROL TO ACCELERATE SEGMENTAL GROWTH
 
 
 
 
 
11.7
EXTRUSION EQUIPMENT
 
 
 
 
 
 
 
11.7.1
GROWING EMPHASIS ON IMPROVING BIOAVAILABILITY OF POORLY SOLUBLE DRUGS TO SPUR DEMAND
 
 
 
 
 
11.8
TABLET COMPRESSION PRESSES
 
 
 
 
 
 
 
11.8.1
LARGE-SCALE PRODUCTION OF TABLETS AND HIGH-VOLUME PRODUCTION REQUIREMENTS TO FUEL SEGMENTAL GROWTH
 
 
 
 
 
11.9
INSPECTION EQUIPMENT
 
 
 
 
 
 
 
11.9.1
HEIGHTENED FOCUS ON QUALITY ASSURANCE AND RISK REDUCTION TO EXPEDITE SEGMENTAL GROWTH
 
 
 
 
 
11.10
GRANULATION EQUIPMENT
 
 
 
 
 
 
 
11.10.1
REQUIREMENT FOR CONSISTENT AND REPRODUCIBLE MANUFACTURING PROCESSES TO BOOST SEGMENTAL GROWTH
 
 
 
 
 
11.11
STERILIZATION EQUIPMENT
 
 
 
 
 
 
 
11.11.1
INCREASING PRODUCTION OF STERILE DRUGS AND REGULATORY SCRUTINY TO FOSTER SEGMENTAL GROWTH
 
 
 
 
12
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2032 in USD Million | 2 Data Tables
 
 
 
 
 
168
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
SOLID
 
 
 
 
 
 
 
12.2.1
STABILITY, EASE OF STORAGE AND TRANSPORT, AND LOW MANUFACTURING COSTS TO AUGMENT SEGMENTAL GROWTH
 
 
 
 
 
12.3
LIQUID
 
 
 
 
 
 
 
12.3.1
HIGH PREFERENCE FOR BIOLOGICS, VACCINES, AND INJECTABLE THERAPIES TO EXPEDITE SEGMENTAL GROWTH
 
 
 
 
13
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2032 in USD Million | 2 Data Tables
 
 
 
 
 
172
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
SEMI-AUTOMATIC
 
 
 
 
 
 
 
13.2.1
MOUNTING DEMAND FOR SMALL-SCALE AND FLEXIBLE PHARMACEUTICAL MANUFACTURING TO FUEL SEGMENTAL GROWTH
 
 
 
 
 
13.3
AUTOMATIC
 
 
 
 
 
 
 
13.3.1
RISING NEED FOR HIGH PRODUCTIVITY AND STRINGENT REGULATORY REQUIREMENTS TO AUGMENT SEGMENTAL GROWTH
 
 
 
 
14
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION
Comprehensive coverage of 10 Regions with country-level deep-dive of 14 Countries | 52 Data Tables.
 
 
 
 
 
176
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
 
 
14.2.1.1
INCREASING INVESTMENT IN COMPLIANCE-READY EQUIPMENT TO STRENGTHEN HEALTHCARE PRODUCTION CAPABILITIES TO DRIVE MARKET
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
 
 
14.2.2.1
MOUNTING ADOPTION OF AUTOMATION AND REGULATORY FRAMEWORKS TO FOSTER MARKET GROWTH
 
 
 
 
 
14.2.3
MEXICO
 
 
 
 
 
 
 
14.2.3.1
RISING DOMESTIC TRACK-AND-TRACE REQUIREMENTS AND EXPORT COMPLIANCE TO SUPPORT MARKET GROWTH
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
 
14.3.1
UK
 
 
 
 
 
 
 
14.3.1.1
GOVERNMENT SUPPORT FOR LIFE SCIENCES SECTOR AND STRONG REGULATORY STANDARDS TO BOOST MARKET GROWTH
 
 
 
 
 
14.3.2
GERMANY
 
 
 
 
 
 
 
14.3.2.1
STRONG ENGINEERING CAPABILITIES, ADVANCED AUTOMATION, AND EARLY ADOPTION OF DIGITAL MANUFACTURING PRACTICES TO DRIVE MARKET
 
 
 
 
 
14.3.3
FRANCE
 
 
 
 
 
 
 
14.3.3.1
HIGH INVESTMENT IN VALIDATED MANUFACTURING, FILLING, INSPECTION, AND PACKAGING EQUIPMENT TO FUEL MARKET GROWTH
 
 
 
 
 
14.3.4
ITALY
 
 
 
 
 
 
 
14.3.4.1
GROWING FOCUS ON STERILE AND HIGH-VALUE MANUFACTURING TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
 
14.3.5
REST OF EUROPE
 
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
 
 
 
14.4.1.1
RISING EMPHASIS ON INNOVATIVE DRUG DEVELOPMENT AND AUTOMATED MANUFACTURING TECHNOLOGIES TO EXPEDITE MARKET GROWTH
 
 
 
 
 
14.4.2
JAPAN
 
 
 
 
 
 
 
14.4.2.1
STRONG FOCUS ON MANUFACTURING PROCESS CONTROL, ACCURACY, AND RELIABILITY TO ACCELERATE MARKET GROWTH
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
 
 
14.4.3.1
LARGE-SCALE GENERIC DRUG MANUFACTURING BASE TO DRIVE MARKET
 
 
 
 
 
14.4.4
SOUTH KOREA
 
 
 
 
 
 
 
14.4.4.1
ADVANCED TECHNOLOGICAL CAPABILITIES AND STRONG REGULATORY FRAMEWORK TO FOSTER MARKET GROWTH
 
 
 
 
 
14.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
14.5
ROW
 
 
 
 
 
 
 
14.5.1
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
14.5.1.1
GCC
 
 
 
 
 
 
 
 
14.5.1.1.1
RISING ADOPTION OF HEALTHCARE LOCALIZATION AND ECONOMIC DIVERSIFICATION STRATEGIES TO BOLSTER MARKET GROWTH
 
 
 
 
14.5.1.2
SOUTH AFRICA
 
 
 
 
 
 
 
 
14.5.1.2.1
INCREASING VACCINE AND BIOLOGICS MANUFACTURING CAPABILITIES TO AUGMENT MARKET GROWTH
 
 
 
 
14.5.1.3
REST OF MIDDLE EAST & AFRICA
 
 
 
 
 
14.5.2
SOUTH AMERICA
 
 
 
 
 
 
 
14.5.2.1
BRAZIL
 
 
 
 
 
 
 
 
14.5.2.1.1
STRONG FOCUS ON COMPLIANCE WITH TRACK-AND-TRACE REGULATIONS TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
14.5.2.2
ARGENTINA
 
 
 
 
 
 
 
 
14.5.2.2.1
MOUNTING DEMAND FOR TABLET COMPRESSION, CAPSULE FILLING, GRANULATION, AND COATING EQUIPMENT TO SUPPORT MARKET GROWTH
 
 
 
 
14.5.2.3
REST OF SOUTH AMERICA
 
 
 
15
COMPETITIVE LANDSCAPE
Decipher key player strategies and market dominance through financial metrics and competitive benchmarking.
 
 
 
 
 
221
 
15.1
OVERVIEW
 
 
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2026
 
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2O25
 
 
 
 
 
 
 
15.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
15.6
BRAND COMPARISON
 
 
 
 
 
 
 
15.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
15.7.1
STARS
 
 
 
 
 
 
15.7.2
EMERGING LEADERS
 
 
 
 
 
 
15.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
15.7.4
PARTICIPANTS
 
 
 
 
 
 
15.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
15.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
15.7.5.2
REGION FOOTPRINT
 
 
 
 
 
 
15.7.5.3
EQUIPMENT TYPE FOOTPRINT
 
 
 
 
 
 
15.7.5.4
END-PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
15.7.5.5
TECHNOLOGY FOOTPRINT
 
 
 
 
15.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
15.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
15.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
15.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
15.8.4
STARTING BLOCKS
 
 
 
 
 
 
15.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
15.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
15.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
15.9.2
DEALS
 
 
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
251
 
16.1
KEY PLAYERS
 
 
 
 
 
 
 
16.1.1
GEA GROUP AKTIENGESELLSCHAFT
 
 
 
 
 
 
 
16.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
16.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
16.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
16.1.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
16.1.1.3.2
DEALS
 
 
 
 
16.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
16.1.1.4.1
KEY STRENGTHS/RIGHT TO WIN
 
 
 
 
 
 
16.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
16.1.1.4.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
16.1.2
KÖRBER AG
 
 
 
 
 
 
16.1.3
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA
 
 
 
 
 
 
16.1.4
SYNTEGON TECHNOLOGY GMBH
 
 
 
 
 
 
16.1.5
ACG
 
 
 
 
 
 
16.1.6
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
16.1.7
ROMACO GROUP
 
 
 
 
 
 
16.1.8
MARCHESINI GROUP S.P.A.
 
 
 
 
 
 
16.1.9
MG2 S.R.L.
 
 
 
 
 
 
16.1.10
GLATT GMBH
 
 
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
 
 
16.2.1
BAUSCH+STRÖBEL SE + CO. KG
 
 
 
 
 
 
16.2.2
COPERION GMBH
 
 
 
 
 
 
16.2.3
ELIZABETH COMPANIES
 
 
 
 
 
 
16.2.4
FETTE COMPACTING
 
 
 
 
 
 
16.2.5
FREUND
 
 
 
 
 
 
16.2.6
KORSCH AG
 
 
 
 
 
 
16.2.7
L.B. BOHLE MASCHINEN UND VERFAHREN GMBH
 
 
 
 
 
 
16.2.8
LFA MACHINES
 
 
 
 
 
 
16.2.9
CVC TECHNOLOGIES, INC.
 
 
 
 
 
 
16.2.10
OHARA TECHNOLOGIES
 
 
 
 
 
 
16.2.11
PRISM PHARMA MACHINERY
 
 
 
 
 
 
16.2.12
SAINTYCO
 
 
 
 
 
 
16.2.13
SILVERSON
 
 
 
 
 
 
16.2.14
YENCHEN MACHINERY CO., LTD.
 
 
 
 
 
 
16.2.15
QUALICAPS
 
 
 
 
 
 
16.2.16
COESIA S.P.A.
 
 
 
 
 
 
16.2.17
UHLMANN
 
 
 
 
 
 
16.2.18
AST, LLC
 
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
302
 
17.1
RESEARCH DATA
 
 
 
 
 
 
 
17.1.1
SECONDARY AND PRIMARY RESEARCH
 
 
 
 
 
 
17.1.2
SECONDARY DATA
 
 
 
 
 
 
 
17.1.2.1
LIST OF KEY SECONDARY SOURCES
 
 
 
 
 
 
17.1.2.2
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
17.1.3
PRIMARY DATA
 
 
 
 
 
 
 
17.1.3.1
LIST OF PRIMARY INTERVIEW PARTICIPANTS
 
 
 
 
 
 
17.1.3.2
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
17.1.3.3
KEY INDUSTRY INSIGHTS
 
 
 
 
 
 
17.1.3.4
BREAKDOWN OF PRIMARIES
 
 
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
17.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
17.2.2
TOP-DOWN APPROACH
 
 
 
 
 
 
17.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
 
 
 
 
 
17.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
 
17.3.1
SUPPLY SIDE
 
 
 
 
 
 
17.3.2
DEMAND SIDE
 
 
 
 
 
17.4
FACTOR ANALYSIS
 
 
 
 
 
 
17.5
DATA TRIANGULATION
 
 
 
 
 
 
17.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
17.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
17.8
RISK ANALYSIS
 
 
 
 
 
18
APPENDIX
 
 
 
 
 
314
 
18.1
INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
 
 
18.2
DISCUSSION GUIDE
 
 
 
 
 
 
18.3
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.4
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
18.5
RELATED REPORTS
 
 
 
 
 
 
18.6
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SUMMARY OF CHANGES
 
 
 
 
 
 
TABLE 3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
TABLE 4
STRATEGIC FOCUS OF MAJOR COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 5
IMPACT OF PORTER’S FIVE FORCES
 
 
 
 
 
 
TABLE 6
GDP GROWTH RATES, BY COUNTRY, 2021–2030 (%)
 
 
 
 
 
 
TABLE 7
ROLE OF COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
 
 
 
 
 
 
TABLE 8
PRICING RANGE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT PROVIDED BY KEY PLAYERS, BY EQUIPMENT TYPE, 2025 (USD)
 
 
 
 
 
 
TABLE 9
AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, 2022–2025 (USD)
 
 
 
 
 
 
TABLE 10
AVERAGE SELLING PRICE TREND OF PACKAGING MACHINES, BY REGION, 2022–2025 (USD)
 
 
 
 
 
 
TABLE 11
IMPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 12
EXPORT DATA FOR HS CODE 8479-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 13
LIST OF KEY CONFERENCES AND EVENTS, 2026
 
 
 
 
 
 
TABLE 14
INOXPA IMPLEMENTS MODULAR PHARMACEUTICAL PROCESSING SYSTEM TO STRENGTHEN AVVA PHARMACEUTICALS’ MANUFACTURING CAPABILITIES
 
 
 
 
 
 
TABLE 15
GEA SUPPLIES PSD-3 PHARMACEUTICAL SPRAY DRYER TO HELP CHUGAI PHARMACEUTICAL PROCESS PHARMACEUTICAL COMPOUNDS
 
 
 
 
 
 
TABLE 16
ZAMBON COMPANY UNITES WITH IMA ACTIVE ON PROCESS OPTIMIZATION PROJECT TO SUPPORT PRODUCTION CAPACITY AND MAINTAIN OPERATIONAL EFFICIENCY
 
 
 
 
 
 
TABLE 17
ACG DEVELOPS RETROFIT SOLUTION TO INCREASE STABILITY AND SHELF LIFE OF INDIAN PHARMACEUTICAL COMPANY
 
 
 
 
 
 
TABLE 18
SYNTEGON’S AIM 5022S PLATFORM HELPS JIANGSU JINDIKE PHARMACEUTICAL ENHANCE INSPECTION EFFICIENCY AND ACCURACY OF PRE-FILLED SYRINGES
 
 
 
 
 
 
TABLE 19
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 20
TECHNOLOGY ROADMAP IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 21
LIST OF KEY PATENTS, 2023–2025
 
 
 
 
 
 
TABLE 22
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
TABLE 23
BEST PRACTICES FOLLOWED BY COMPANIES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 24
CASE STUDIES ON AI IMPLEMENTATION IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 25
INTERCONNECTED ECOSYSTEM AND IMPACT ON PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET PLAYERS
 
 
 
 
 
 
TABLE 26
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 27
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 28
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 29
ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 30
PHARMACEUTICAL MANUFACTURING EQUIPMENT INDUSTRY STANDARDS
 
 
 
 
 
 
TABLE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE (%)
 
 
 
 
 
 
TABLE 32
KEY BUYING CRITERIA FOR END-PRODUCT TYPES
 
 
 
 
 
 
TABLE 33
UNMET NEEDS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
 
 
 
 
 
 
TABLE 34
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 35
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 36
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 37
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (THOUSAND UNITS)
 
 
 
 
 
 
TABLE 38
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 39
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 40
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 41
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 42
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 43
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 44
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 45
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 46
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 47
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 48
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 49
PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 50
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 51
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 52
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 53
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 54
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 55
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 56
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 57
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 58
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 59
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 60
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 61
FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 62
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 63
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 64
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 65
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 66
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 67
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 68
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 69
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 70
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 71
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 72
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 73
SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 75
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 76
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 77
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 79
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 81
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 82
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 83
MIXING & BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 84
MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 85
MIXING & BLENDING: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 86
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 89
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 90
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 91
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 92
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 94
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 95
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 96
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 97
MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 98
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 99
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 100
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 101
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 102
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 103
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 104
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 105
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 106
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 107
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 108
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 110
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 111
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 112
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 113
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 114
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 115
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 116
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 117
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 118
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 119
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 120
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 121
TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 122
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 123
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 124
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 125
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 126
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 127
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 128
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 129
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 130
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 131
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 132
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 133
INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 134
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 135
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 136
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 137
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 138
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 139
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 140
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 141
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 142
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 143
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GRANULATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 146
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 147
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 148
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 149
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 150
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 151
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 152
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 153
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 154
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 155
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 156
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 157
STERILIZATION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 158
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 159
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2026–2032, (USD MILLION)
 
 
 
 
 
 
TABLE 160
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 161
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY, 2026–2032, (USD MILLION)
 
 
 
 
 
 
TABLE 162
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 163
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 164
NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 165
NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 166
NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 167
NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 168
US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 169
US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 170
CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 171
CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 172
MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 173
MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 174
EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 175
EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 176
EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 177
EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 178
UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 179
UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 180
GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 181
GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 182
FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 183
FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 186
REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 187
REST OF EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 190
ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 192
CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 193
CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 194
JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 195
JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 196
INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 197
INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 198
SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 199
SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 200
REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 201
REST OF ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 202
ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 203
ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 204
ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 205
ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 206
MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 207
MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 208
MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 209
MIDDLE EAST & AFRICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 210
SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 211
SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 212
SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2021–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 213
SOUTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2026–2032 (USD MILLION)
 
 
 
 
 
 
TABLE 214
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2022–JANUARY 2026
 
 
 
 
 
 
TABLE 215
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEGREE OF COMPETITION, 2025
 
 
 
 
 
 
TABLE 216
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 217
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EQUIPMENT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 218
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: END-PRODUCT TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 219
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 220
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 221
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 222
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, JANUARY 2022−JANUARY 2026
 
 
 
 
 
 
TABLE 223
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2022−JANUARY 2026
 
 
 
 
 
 
TABLE 224
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: EXPANSIONS, JANUARY 2022−JANUARY 2026
 
 
 
 
 
 
TABLE 225
GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 226
GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 227
GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 228
GEA GROUP AKTIENGESELLSCHAFT: DEALS
 
 
 
 
 
 
TABLE 229
KÖRBER AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 230
KÖRBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 231
KÖRBER AG: DEALS
 
 
 
 
 
 
TABLE 232
KÖRBER AG: EXPANSIONS
 
 
 
 
 
 
TABLE 233
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 234
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCTS/ SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 235
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 236
IMA INDUSTRIA MACCHINE AUTOMATICHE SPA: DEALS
 
 
 
 
 
 
TABLE 237
SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 238
SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 239
SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 240
SYNTEGON TECHNOLOGY GMBH: DEALS
 
 
 
 
 
 
TABLE 241
SYNTEGON TECHNOLOGY GMBH: EXPANSIONS
 
 
 
 
 
 
TABLE 242
ACG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 243
ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 244
ACG: DEALS
 
 
 
 
 
 
TABLE 245
ACG: EXPANSIONS
 
 
 
 
 
 
TABLE 246
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 247
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 248
THERMO FISHER SCIENTIFIC INC.: DEALS
 
 
 
 
 
 
TABLE 249
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
 
 
 
 
 
 
TABLE 250
ROMACO GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 251
ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 252
ROMACO GROUP: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 253
ROMACO GROUP: DEALS
 
 
 
 
 
 
TABLE 254
MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 255
MARCHESINI GROUP S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 256
MARCHESINI GROUP S.P.A.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 257
MARCHESINI GROUP S.P.A.: DEALS
 
 
 
 
 
 
TABLE 258
MG2 S.R.L.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 259
MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 260
MG2 S.R.L.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 261
GLATT GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 262
GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 263
BAUSCH+STRÖBEL SE + CO. KG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 264
COPERION GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 265
ELIZABETH COMPANIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 266
FETTE COMPACTING: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 267
FREUND: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 268
KORSCH AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 269
L.B. BOHLE MASCHINEN UND VERFAHREN GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 270
LFA MACHINES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 271
CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 272
OHARA TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 273
PRISM PHARMA MACHINERY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 274
SAINTYCO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 275
SILVERSON: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 276
YENCHEN MACHINERY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 277
QUALICAPS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 278
COESIA S.P.A.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 279
UHLMANN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 280
AST, LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 281
MAJOR SECONDARY SOURCES
 
 
 
 
 
 
TABLE 282
PRIMARY INTERVIEW PARTICIPANTS
 
 
 
 
 
 
TABLE 283
DATA CAPTURED FROM PRIMARY SOURCES
 
 
 
 
 
 
TABLE 284
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RISK ANALYSIS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DURATION COVERED
 
 
 
 
 
 
FIGURE 3
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2021–2032
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, JANUARY 2022–JANUARY 2026
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, 2026–2032
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
HIGH EMPHASIS ON AUTOMATING PRODUCTION AND IMPROVING THROUGHPUT TO DRIVE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
 
 
 
 
 
 
FIGURE 10
PACKAGING MACHINES SEGMENT TO CAPTURE LARGEST MARKET SHARE IN 2026 AND 2032
 
 
 
 
 
 
FIGURE 11
LIQUID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2032
 
 
 
 
 
 
FIGURE 12
AUTOMATIC TECHNOLOGY TO DOMINATE MARKET SHARE FROM 2026 TO 2032
 
 
 
 
 
 
FIGURE 13
PACKAGING MACHINES SEGMENT AND US TO HOLD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA IN 2032
 
 
 
 
 
 
FIGURE 14
INDIA TO BE FASTEST-GROWING MARKET FOR PHARMACEUTICAL MANUFACTURING EQUIPMENT DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 15
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 16
IMPACT ANALYSIS: DRIVERS
 
 
 
 
 
 
FIGURE 17
IMPACT ANALYSIS: RESTRAINTS
 
 
 
 
 
 
FIGURE 18
IMPACT ANALYSIS: OPPORTUNITIES
 
 
 
 
 
 
FIGURE 19
IMPACT ANALYSIS: CHALLENGES
 
 
 
 
 
 
FIGURE 20
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 21
PHARMACEUTICAL MANUFACTURING EQUIPMENT VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 22
PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
 
 
 
 
 
 
FIGURE 23
AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, 2022–2025
 
 
 
 
 
 
FIGURE 24
AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL PACKAGING MACHINES, BY REGION, 2022–2025
 
 
 
 
 
 
FIGURE 25
INVESTMENT AND FUNDING SCENARIO, 2020–2024
 
 
 
 
 
 
FIGURE 26
IMPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021–2025
 
 
 
 
 
 
FIGURE 27
EXPORT SCENARIO FOR HS CODE 8479-COMPLIANT PRODUCTS IN TOP FIVE COUNTRIES, 2021–2025
 
 
 
 
 
 
FIGURE 28
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 29
PATENT APPLIED AND GRANTED, 2016–2025
 
 
 
 
 
 
FIGURE 30
DECISION-MAKING FACTORS CONSIDERED WHILE BUYING PHARMACEUTICAL MANUFACTURING EQUIPMENT
 
 
 
 
 
 
FIGURE 31
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END-PRODUCT TYPE
 
 
 
 
 
 
FIGURE 32
KEY BUYING CRITERIA, BY END-PRODUCT TYPE
 
 
 
 
 
 
FIGURE 33
PHARMACEUTICAL MANUFACTURING EQUIPMENT ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
FIGURE 34
PHARMACEUTICAL MANUFACTURING EQUIPMENT END USERS
 
 
 
 
 
 
FIGURE 35
MAJOR PHARMACEUTICAL EQUIPMENT MANUFACTURING PROCESSES
 
 
 
 
 
 
FIGURE 36
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
 
 
 
 
 
 
FIGURE 37
PACKAGING MACHINES SEGMENT TO DOMINATE MARKET FROM 2026 TO 2032
 
 
 
 
 
 
FIGURE 38
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
 
 
 
 
 
 
FIGURE 39
SOLID SEGMENT TO ACCOUNT FOR LARGER SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026
 
 
 
 
 
 
FIGURE 40
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY TECHNOLOGY
 
 
 
 
 
 
FIGURE 41
AUTOMATIC SEGMENT TO CAPTURE LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2026
 
 
 
 
 
 
FIGURE 42
ASIA PACIFIC TO EXHIBIT HIGHEST CAGR BETWEEN 2026 AND 2032
 
 
 
 
 
 
FIGURE 43
NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 44
EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 45
ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 46
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REVENUE ANALYSIS OF TOP PLAYER, 2020–2024
 
 
 
 
 
 
FIGURE 47
MARKET SHARE ANALYSIS OF COMPANIES OFFERING PHARMACEUTICAL MANUFACTURING EQUIPMENT, 2025
 
 
 
 
 
 
FIGURE 48
COMPANY VALUATION
 
 
 
 
 
 
FIGURE 49
FINANCIAL METRICS (EV/EBITDA)
 
 
 
 
 
 
FIGURE 50
BRAND COMPARISON
 
 
 
 
 
 
FIGURE 51
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY COMPANIES), 2025
 
 
 
 
 
 
FIGURE 52
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 53
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 54
GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 55
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 56
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 57
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH APPROACH
 
 
 
 
 
 
FIGURE 58
DATA CAPTURED FROM SECONDARY SOURCES
 
 
 
 
 
 
FIGURE 59
CORE FINDINGS FROM INDUSTRY EXPERTS
 
 
 
 
 
 
FIGURE 60
BREAKDOWN OF PRIMARY INTERVIEW, BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 61
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 62
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 63
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE ESTIMATION (SUPPLY SIDE)
 
 
 
 
 
 
FIGURE 64
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: FACTOR ANALYSIS
 
 
 
 
 
 
FIGURE 65
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DATA TRIANGULATION
 
 
 
 
 
 
FIGURE 66
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH ASSUMPTIONS
 
 
 
 
 
 
FIGURE 67
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
 
 

Methodology

The research process for this study involved the systematic gathering, recording, and analysis of data on customers and companies operating in the pharmaceutical manufacturing equipment market. This process involved the extensive use of secondary sources, directories, and databases (Factiva and Oanda) to identify and collect valuable information for the comprehensive, technical, market-oriented, and commercial study of the pharmaceutical manufacturing equipment market. In-depth interviews were conducted with primary respondents, including experts from core and related industries, as well as preferred manufacturers, to obtain and verify critical qualitative and quantitative information and assess growth prospects. Key players in the pharmaceutical manufacturing equipment market were identified through secondary research, and their market rankings were determined through a combination of primary and secondary research. This research involved studying the annual reports of top players and conducting interviews with key industry experts, including CEOs, directors, and marketing executives.

Secondary Research

Various sources were utilized in the secondary research process to identify and collect information relevant to this study. These include company annual reports, press releases, investor presentations, white papers, technology journals, certified publications, articles by recognized authors, directories, and databases. Secondary research was primarily used to gather key information about the industry’s value chain, the total pool of market players, market classification according to industry trends at the most detailed level, regional markets, and key developments from both market and technology-oriented perspectives.

Primary Research

Primary research was conducted to identify the segmentation types, key players, competitive landscape, and key market dynamics, including drivers, restraints, opportunities, challenges, and industry trends, as well as key strategies adopted by players operating in the pharmaceutical manufacturing equipment market. Extensive qualitative and quantitative analyses were performed on the complete market engineering process to list key information and insights throughout the report.
Extensive primary research has been conducted after gaining insights into the pharmaceutical manufacturing equipment market scenarios through secondary research. Several primary interviews were conducted with experts from the demand (region) and supply side (equipment type, end-product type, and technology) across four major geographic regions: North America, Europe, Asia Pacific, and RoW. Approximately 60% and 40% of the primary interviews were conducted from the supply and demand sides, respectively. These primary data have been collected through questionnaires, emails, and telephonic interviews.

Pharmaceutical Manufacturing Equipment Market Size, and Share

Notes: The three tiers of companies have been defined based on their total/segmental revenue as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million–USD 1 billion, and Tier 3 = <USD 500 million.
Other designations include sales, marketing, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In the complete market engineering process, top-down and bottom-up approaches and several data triangulation methods were implemented to estimate and validate the size of the pharmaceutical manufacturing equipment market and various other dependent submarkets. Key players were identified through secondary research, and their market share in the respective regions was determined through a combination of primary and secondary research. This entire research methodology involved studying the annual and financial reports of the top players, as well as conducting interviews with experts (CEOs, VPs, directors, and marketing executives) to gather key insights (both quantitative and qualitative).

All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Pharmaceutical Manufacturing Equipment Market : Top-Down and Bottom-Up Approach

Pharmaceutical Manufacturing Equipment Market Top Down and Bottom Up Approach

Data Triangulation

After determining the overall market size through the estimation process, as explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, market breakdown and data triangulation procedures were employed, as applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market has been validated using both top-down and bottom-up approaches.

Market Definition

The pharmaceutical manufacturing equipment market covers the global ecosystem involved in the development, production, processing, and packaging of pharmaceutical products across solid and liquid formulations. It includes machinery and integrated systems designed to ensure precision and sterility. These systems maintain regulatory compliance and operational efficiency. Equipment supports activities from raw material handling to final packaging. Manufacturers use these systems to maintain product quality. Large-scale and contract facilities rely on advanced machinery to optimize throughput.

The pharmaceutical manufacturing equipment market is segmented by equipment type, such as packaging machines and filling machines. Spray drying equipment and mixing & blending machines are also included. Milling equipment and extrusion equipment support formulation processes. Tablet compression presses and inspection equipment ensure quality control. Granulation and sterilization equipment are also key categories. By end-product type, the market includes solid and liquid formulations. By technology, the market consists of semi-automatic and automatic systems. Automation improves productivity and reduces manual intervention. Growing pharmaceutical production supports equipment demand. Expansion of biologics and generics manufacturing drives modernization. Investment in advanced manufacturing technologies strengthens global market growth.

Key Stakeholders

  • Pharmaceutical manufacturing equipment manufacturers
  • End users
  • Automation consultants
  • Research organizations
  • Technology investors
  • Technology standards organizations, forums, alliances, and associations
  • Process automation and instrumentation solution and product suppliers
  • Instrumentation and automation products’ original equipment manufacturers (OEMs)
  • Energy industry associations

Report Objectives

  • To describe and forecast the pharmaceutical manufacturing equipment market, by equipment type, end-product type, and technology, in terms of value
  • To forecast the market size for four key regions, namely North America, Europe, Asia Pacific, and the Rest of the World (RoW), along with their country-level analyses, in terms of value
  • To estimate the market size, by equipment type, in terms of volume
  • To provide detailed information regarding the major factors influencing the growth of the market, namely, drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  • To study the complete value chain of the pharmaceutical manufacturing equipment ecosystem, along with market trends and use cases
  • To analyze opportunities for stakeholders in the market by identifying high-growth segments of the market
  • To strategically profile key players and comprehensively analyze their core competencies2, along with detailing the competitive landscape for market leaders
  • To analyze competitive developments, such as product launches, mergers, acquisitions, partnerships, collaborations, and expansions, in the pharmaceutical manufacturing equipment market.
  • To benchmark market players using the company evaluation matrix, which analyzes players based on various parameters within broad business categories and product strategies
  • To provide information on Porter’s five forces analysis, pricing analysis, trade analysis, investment and funding scenario, key conferences and events, regulatory landscape, ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs of various equipment types, interconnected markets and cross-sector opportunities, macroeconomic outlook, and the impact of AI, and the impact of 2025 US tariff
  • To benchmark market players using the company evaluation quadrant, which analyzes players based on various parameters within broad business categories and product strategies
  • To provide a macroeconomic outlook for all regions covered in this report
  • To provide information on ecosystem analysis, case study analysis, patent analysis, technology analysis, unmet needs from various applications, interconnected markets, and cross-sector opportunities, and the impact of AI and its use cases, and the 2025 US tariff impact

Available customizations:

With the given market data, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Manufacturing Equipment Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Pharmaceutical Manufacturing Equipment Market

Turn Research into Strategy in Minutes. Generate 15+ consulting-grade intelligence outputs instantly
Interactive dashboards | Proprietary market intelligence
Try GrowthIQ →
DMCA.com Protection Status